Swami U - Search Results

1

Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.

Li H, Sahu KK, Brundage J, Benson M, Swami U, Boucher KM, Gupta S, Hawks J, Sirohi D, Agarwal N, Maughan BL. Li H, et al. Among authors: swami u. Oncologist. 2023 Aug 3;28(8):737-e693. doi: 10.1093/oncolo/oyad019. Oncologist. 2023. PMID: 36952231 Free PMC article. Clinical Trial.

2

Eribulin -- a review of preclinical and clinical studies.

Swami U, Chaudhary I, Ghalib MH, Goel S. Swami U, et al. Crit Rev Oncol Hematol. 2012 Feb;81(2):163-84. doi: 10.1016/j.critrevonc.2011.03.002. Epub 2011 Apr 14. Crit Rev Oncol Hematol. 2012. PMID: 21493087 Free PMC article. Review.

3

Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.

Swami U, Goel S, Mani S. Swami U, et al. Curr Drug Targets. 2013 Jun;14(7):777-97. doi: 10.2174/1389450111314070007. Curr Drug Targets. 2013. PMID: 23597015 Free PMC article. Review.

4

Eribulin mesilate, a halichondrin B analogue, in the treatment of breast cancer.

Mani S, Swami U. Mani S, et al. Among authors: swami u. Drugs Today (Barc). 2010 Sep;46(9):641-53. doi: 10.1358/dot.2010.46.9.1519020. Drugs Today (Barc). 2010. PMID: 20967296

5

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together.

Swami U, Zakharia Y, Zhang J. Swami U, et al. J Immunother. 2018 Oct;41(8):359-360. doi: 10.1097/CJI.0000000000000232. J Immunother. 2018. PMID: 29781826 Review.

6

Experience with vena cava filters at a large community hospital and level-I trauma center: indications, complications, and compliance barriers.

Swami U, Annunziata G, Fulger I. Swami U, et al. Clin Appl Thromb Hemost. 2014 Jul;20(5):546-52. doi: 10.1177/1076029613505766. Epub 2013 Oct 1. Clin Appl Thromb Hemost. 2014. PMID: 24085746 Free article. Clinical Trial.

7

Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma.

Swami U, Swick B, Zakharia Y, Milhem M. Swami U, et al. Case Rep Oncol Med. 2019 Mar 7;2019:4683531. doi: 10.1155/2019/4683531. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 30963012 Free PMC article.

8

Eribulin in Cancer Treatment.

Swami U, Shah U, Goel S. Swami U, et al. Mar Drugs. 2015 Aug 7;13(8):5016-58. doi: 10.3390/md13085016. Mar Drugs. 2015. PMID: 26262627 Free PMC article. Review.

9

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.

Swami U, Grivas P, Agarwal N. Swami U, et al. Oncologist. 2019 May;24(5):580-583. doi: 10.1634/theoncologist.2019-0161. Epub 2019 Mar 29. Oncologist. 2019. PMID: 30926675 Free PMC article.

10

Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement.

Swami U, Nussenzveig RH, Haaland B, Agarwal N. Swami U, et al. Ann Transl Med. 2019 Mar;7(Suppl 1):S18. doi: 10.21037/atm.2019.01.50. Ann Transl Med. 2019. PMID: 31032299 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page